Any current/future new fundraising through debt or equity?

There is no mention of any current or planned fundraising through debt or equity in the transcript. The company discusses its growth, deal pipeline, and headcount plans, but does not indicate any intentions regarding raising capital. Financial strategies during the period focus on managing headcount and pursuing large deals for growth rather than external fundraising. The omnibus approval related to JLR is for internal operational limits and not a fundraising activity. Overall, Tata Elxsi appears focused on organic growth and improving execution rather than seeking external funding from debt o

Any current/future capex/capital investment/strategic investment?

Tata Elxsi is actively investing in products, solutions, and IPs aimed at enhancing efficiency and helping customers reduce costs. The company is evaluating opportunities in new industry verticals and plans to announce a strategic focus on building these newer verticals in the next financial year. There is an expressed interest in the defense and semiconductor sectors, with ongoing engagements and potential investments to rebuild capabilities, especially in chip design. No specific current or future capex amounts or detailed strategic investment figures were disclosed in the transcript. The co

Future growth expectations in sales/revenue/volumes?

Tata Elxsi is confident of better growth in H2 FY25 compared to H1, aiming for double-digit constant currency growth by year-end. Growth driven by ramp-up of recently won large deals, especially in transportation and automotive OEM segments. Pipeline includes deals from Asia and Japan, with some OEMs hurrying to catch up, providing new opportunities. JLR business continues to grow steadily but there's faster growth expected from other OEMs. Transportation vertical expected to sustain growth in H2 due to existing and new deal ramp-ups. Healthcare vertical has bottomed out, with growth

Future growth expectations in earnings/operating earnings/profits/EPS?

Tata Elxsi aims for better growth in FY25 compared to FY24, targeting double-digit constant currency growth, although this is acknowledged as a challenging goal. (Page 13) Growth confidence is based on a healthy deal pipeline, including large deals primarily with automotive OEMs, especially in Asia and Japan, where OEMs are catching up, driving new opportunities. (Page 14) Transportation vertical is expected to continue powering growth with ramp-ups from large deals won and faster growth from OEMs compared to Tier 1 suppliers. (Pages 8, 11, 13) Healthcare and media verticals are showing signs

Current/ Expected Orderbook/ Pending Orders?

Tata Elxsi has a healthy deal pipeline with good visibility for new orders. The company is confident of closing 1 or 2 large deals every quarter rather than needing multiple deals. Some deals are emerging from Asia and Japan, regions where OEMs are catching up. Large deals secured include a landmark US$50 million multi-year deal from a global OEM. Ramp-ups for some large deals have started or will start soon (e.g., ramp-ups from January onwards for a 5-year deal). The company is actively bidding for additional deals that could contribute to growth in H2 FY25. Even though the auto industry is f

Tata ElxsiQ2 FY25

Tata Elxsi Q2 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹3,790P/E: 32.8Market Cap: ₹23.6K Cr

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

Yes

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 3

Tata Elxsi is confident of better growth in H2 FY25 compared to H1, aiming for double-digit constant currency growth by year-end.
Growth driven by ramp-up of recently won large deals, especially in transportation and automotive OEM segments.
Pipeline includes deals from Asia and Japan, with some OEMs hurrying to catch up, providing new opportunities.
JLR business continues to grow steadily but there's faster growth expected from other OEMs.
Transportation vertical expected to sustain growth in H2 due to existing and new deal ramp-ups.
Healthcare vertical has bottomed out, with growth and new projects anticipated from Q3/Q4.
Media and Communications remain challenging but green shoots of growth from network transformation and AI innovations are visible.
New industry verticals are being evaluated to diversify growth in the future.
Headcount growth to be cautious, focused on critical freshers and specialized skills aligned with project needs.

Margin guidance

Category 3

Tata Elxsi aims for better growth in FY25 compared to FY24, targeting double-digit constant currency growth, although this is acknowledged as a challenging goal. (Page 13)
Growth confidence is based on a healthy deal pipeline, including large deals primarily with automotive OEMs, especially in Asia and Japan, where OEMs are catching up, driving new opportunities. (Page 14)
Transportation vertical is expected to continue powering growth with ramp-ups from large deals won and faster growth from OEMs compared to Tier 1 suppliers. (Pages 8, 11, 13)
Healthcare and media verticals are showing signs of recovery and bottoming out, with some partial restarts expected in Q3 and full recovery anticipated by Q4. (Pages 9, 10)
Margins are expected to improve in H2 relative to H1, with operating margin expansion already noted in Q2. (Pages 5, 9)
Headcount hiring is cautious with fresher hiring planned in H2, and utilization around 69.5% indicating capacity for growth without immediate large-scale hiring. (Pages 7, 12)

See what Tata Elxsi management said on margin guidance — free account, 30 seconds.

Fundraise plans

There is no mention of any current or planned fundraising through debt or equity in the transcript.
The company discusses its growth, deal pipeline, and headcount plans, but does not indicate any intentions regarding raising capital.
Financial strategies during the period focus on managing headcount and pursuing large deals for growth rather than external fundraising.
The omnibus approval related to JLR is for internal operational limits and not a fundraising activity.
Overall, Tata Elxsi appears focused on organic growth and improving execution rather than seeking external funding from debt or equity markets at this time.

Order book

Yes

Tata Elxsi has a healthy deal pipeline with good visibility for new orders.
The company is confident of closing 1 or 2 large deals every quarter rather than needing multiple deals.
Some deals are emerging from Asia and Japan, regions where OEMs are catching up.
Large deals secured include a landmark US$50 million multi-year deal from a global OEM.
Ramp-ups for some large deals have started or will start soon (e.g., ramp-ups from January onwards for a 5-year deal).
The company is actively bidding for additional deals that could contribute to growth in H2 FY25.
Even though the auto industry is facing turmoil, Tata Elxsi expects these key deals to keep the business afloat and help achieve double-digit constant currency growth.
The omnibus approval for JLR allows for potential INR1,000 crores opportunity over 2 years, though not all expected in the near term.

See what Tata Elxsi management said on order book — free account, 30 seconds.

Capex plans

Yes

Tata Elxsi is actively investing in products, solutions, and IPs aimed at enhancing efficiency and helping customers reduce costs.
The company is evaluating opportunities in new industry verticals and plans to announce a strategic focus on building these newer verticals in the next financial year.
There is an expressed interest in the defense and semiconductor sectors, with ongoing engagements and potential investments to rebuild capabilities, especially in chip design.
No specific current or future capex amounts or detailed strategic investment figures were disclosed in the transcript. The company is cautiously managing headcount and resource allocation, focusing on critical hires aligned with project needs.
Overall, the emphasis is on strategic and capability-building investments rather than heavy capital expenditures at this time.

Track Tata Elxsi — get its next earnings analysis in your feed

How does Tata Elxsi rank vs peers in ?

Pro feature

ThisTata Elxsi

Rev 3Mar 3

See where Tata Elxsi sits in See which companies these are, and every other name in the sector.Open rankings

What Tata Elxsi's management said in earlier quarters

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Tata Elxsi Q2 FY25 Earnings Call Analysis

Revenue guidance

Fundraise plans

Capex plans

Continue your research

What Tata Elxsi's management said in earlier quarters